New hope for bladder cancer: maintenance drug aims to keep tumors at bay
NCT ID NCT07460245
First seen Mar 26, 2026 · Last updated May 05, 2026 · Updated 3 times
Summary
This study tests whether the drug avelumab can help keep advanced bladder cancer from getting worse after initial chemotherapy. About 144 people who have already received two prior treatments will receive avelumab as a maintenance therapy. The main goal is to see how long the cancer stays controlled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AO Santa Maria della Misericordia di Perugia-Struttura Complessa di Oncologia Medica
Terni, TR, 06132, Italy
Contact
-
AOU Careggi
Florence, FI, 50134, Italy
Contact
-
Aou Federico Ii - Uoc Di Oncologia Medica
Naples, 80131, Italy
Contact
-
Ausl/Irccs Di Reggio Emilia - S.O.C. Oncologia Medica Provinciale
Reggio Emilia, RE, 42123, Italy
Contact
-
Irccs San Raffaele - Milano
Milan, MI, 20132, Italy
Contact
-
Istituto Romagnolo Per Lo Studio Dei Tumori "Dino Amadori" Irccs Irst
Meldola, FC, 47014, Italy
Contact
-
Oncologia Medica Universitaria, Azienda Ospedaliera Universitaria Consorziale Policlinico Di Bari
Bari, BA, Italy
Contact
-
POLICLINICO RIUNITI FOGGIA Oncologia Medica
Foggia, FG, 71122, Italy
Contact
-
UOC ONCOLOGIA MEDICA IRCCS Ospedale Policlinico San Martino
Genova, GE, 16132, Italy
Contact
-
UOC Oncologia Medica AOU di Verona
Verona, VR, 37126, Italy
Contact
-
UOC di Oncologia Medica 2 IOV Istituto Oncologico Veneto
Padova, PD, 35128, Italy
Contact
-
UOC di Oncologia Medica AOU Policlinico S. Orsola Malpighi
Bologna, BO, 40138, Italy
Contact
-
Uoc Oncologia - Ospedale Di Macerata
Macerata, MC, 62100, Italy
Contact
-
Uoc Oncologia Medica A.R.Na.S.Civico Benefratelli Di Cristina
Palermo, PA, 90127, Italy
Contact
-
Uoc Oncologia Medica Aorn Cardarelli Napoli
Naples, 80131, Italy
Contact
-
Uoc Oncologia Medica Aou Parma
Parma, PR, 43126, Italy
Contact
-
Uoc Oncologia Medica Fondazione Irccs Istituto Nazionale Dei Tumori
Milan, MI, 20133, Italy
Contact
-
Uoc Oncologia Medica Fondazione Policlinico Universitario A. Gemelli Irccs
Roma, RM, 00168, Italy
Contact
-
Uoc Oncologia Medica- Azienda Ospedaliero-Universitaria Di Modena
Modena, MO, 41124, Italy
Contact
Conditions
Explore the condition pages connected to this study.